Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
RecruitingNCT05664412Phase: NAStarted 2023-10-20
Summary
The purpose of this project is to explore the effects of transcranial alternating current stimulation (tACS) in children, adolescents and young adults with a 22q11.2 microdeletion. The main aim of the
Eligibility
Sex
ALL
Min Age
14 Years
Max Age
25 Years
Locations
University of GenevaGeneva, Canton of Geneva, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05664412